Harvard University has filed a lawsuit against the US government after more than $2 billion in federal research funding was ...

US biotech major Regeneron Pharmaceuticals has announced a significant expansion of its manufacturing capacity through a new ...

San Diego-based iBio, an AI-driven innovator of precision antibody therapies, has announced a licensing agreement with ...

Galapagos (Euronext: GLPG) has appointed Henry Gosebruch as chief executive of its upcoming oncology spin-off, marking a ...

Russian public procurements of drugs based on the active ingredient semaglutide, which is an original drug from Denmark’s ...

US biotech major Gilead Sciences (Nasdaq: GILD) today announced positive top-line results from the Phase III ...

Japan’s Ono Pharmaceutical and privately-held US firm Jorna Therapeutics are ready to go in a research collaboration ...

US clinical-stage biotech Halda Therapeutics today announced that Dr Eyal Attar has joined the company as chief medical ...

Zymeworks (Nasdaq: ZYME), a clinical-stage biotech developing antibody-based therapies for cancer and immune diseases, has ...

Physician attitudes toward patient choice between the use of biologics and biosimilars vary widely across global markets, ...

South Korea-based biotech firms 1ST Biotherapeutics and LigaChem Biosciences (Kosdaq: 141080) have entered a strategic ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...